Singapore markets closed

Vanda Pharmaceuticals Inc. (0LKB.L)

LSE - LSE Delayed Price. Currency in USD
Add to watchlist
4.3750+0.0850 (+1.98%)
As of 04:35PM GMT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.68
52-week change 3-32.85%
S&P500 52-week change 327.79%
52-week high 36.8800
52-week low 30.0000
50-day moving average 33.9629
200-day moving average 34.9171

Share statistics

Avg vol (3-month) 33.27k
Avg vol (10-day) 33.88k
Shares outstanding 552.45M
Implied shares outstanding 6N/A
Float 852.32M
% held by insiders 15.53%
% held by institutions 192.29%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 1.30%
Operating margin (ttm)-15.67%

Management effectiveness

Return on assets (ttm)-1.36%
Return on equity (ttm)0.47%

Income statement

Revenue (ttm)192.64M
Revenue per share (ttm)3.36
Quarterly revenue growth (yoy)-29.80%
Gross profit (ttm)N/A
EBITDA -10.94M
Net income avi to common (ttm)2.51M
Diluted EPS (ttm)0.3230
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)388.26M
Total cash per share (mrq)6.75
Total debt (mrq)9.4M
Total debt/equity (mrq)1.73%
Current ratio (mrq)4.94
Book value per share (mrq)9.47

Cash flow statement

Operating cash flow (ttm)12.8M
Levered free cash flow (ttm)-88.78M